Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Viral Gastroenteritis Market is currently going through some of the industry trends in healthcare which is the response of the sector to the challenge of the viral infections that causes the gastrointestinal tract to be affected by the viruses." There is a trend in the market on preventive strategies now weighing heavily on vaccination against the particular virus which causes the diarrhea/intestinal disorders. Vaccines for rotavirus, the most frequent viral cause of gastroenteritis in children, as well as hospitalizations due to diarrhea, have gained a much-needed spotlight to the crucial role their administration has on child health. This growing trend serves as an example of how a more successful rather than a defensive strategy is needed in order to reduce the disease through vaccination – prevention is better than cure.
Additionally, one of the more significant lines in the viral gastroenteritis market is the emergence and acceptance of antiviral drugs as well. Researchers and drug manufactures are going into exploring various new antiviral drugs that can be targeted specifically to the virus that causes gastroenteritis in an attempt to shorten the course and decrease the severity of the symptom. Although emergence of this trend can be seen as a leap in viral gastroenteritis treatment, it only changes the world for affected individuals and their caretakers.
In addition to the flooding market on anti-viral drugs, the diabetic platform is also observing an increase in the use of diagnostic equipment for viral gastroenteritis pathogens detection for more speed and accuracy. Molecular diagnostic methods, PCR and nucleic acid amplification tests are the techniques which possess power to achieve the detailed identification of the virual agents based on which fastest and accurate therapies can be conducted. This trend justifies an argument on the relevance of appropriate diagnostics in the correct handling of the viral kind of gastroenteritis.
Moreover, more and longer case studies are being carried out with regards the viability of introducing probiotics as a way of alleviating viral gastroenteritis. Probiotics, which are the living microorganisms which is good to us in building and maintaining a healthy microbiome, are now researches specifically for the purposes of alleviating viral infection related symptoms like the severity and the duration. Such an emanation testifies that, on the whole, people nowmore want holistic approaches oriented to the gastrointestinal tract with the intent to accelerate the recovery from viral gastroenteritis.
In addition, the outbreak is causing disruption in supply chains and delays in the distribution of critical medical products, particularly in the healthcare sector. Viral gastroenteritis is highly contagious and therefore IACs (Infection Control Practices) are even more crucial whilst these include: Hand hygiene , isolation precautions, and Environmental cleaning and so forth. This pattern nonetheless prompts healthcare to consider effective strategies for stopping the gastroenteritis viruses virus spread in healthcare facilities and community settings.
Taking people education campaign and the awareness into account, expansion of viral gastroenteritis market is considered as one of key factors in this sphere. Educating people regarding transmission modes, common features, and constructive actions in case of viral gastroenteritis allows for timely identification and effective treatment. Hereby, the trend emphasizes the role of different public health measure in decreasing the contribution of viral gastroenteritis in people and the community as well.
Viral Gastroenteritis Market Highlights:
Global Viral Gastroenteritis Market Overview
The Viral Gastroenteritis Market Size was valued at USD 47.31 Billion in 2023. The Global Viral Gastroenteritis industry is projected to grow from USD 49.63 Billion in 2024 to USD 72.77 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.10% during the forecast period (2024 - 2032).
Viral gastroenteritis, also known as stomach flu, is inflammation of the lining of the stomach, small intestine, and large intestine.
There are a number of viruses leading viral gastroenteritis such as norovirus, rotavirus, astrovirus and enteric adenovirus. Norovirus and rotavirus are the most common causes of this disease. This disease is transmitted through direct contact with the patient, and contaminated water or food. The main focus of treating the disease is rehydration by drinking enough water or fluids.
Viral Gastroenteritis Market Trends
The market for viral gastroenteritis is driven by an increasing prevalence of gastrointestinal diseases, availability of cost effective treatment and extensive research and development activities in internal medicine Furthermore, there is an increasing demand for the new drugs for the treatment of the disease.
Bacterial resistance to commonly used antibiotics such as penicillin and amoxicillin may be the leading restrain for the growth of the market. Fierce competition among key market players acts as a barrier for the new entrant in the market.
According to the World Health Organization (WHO), diarrheal diseases are a major cause of hospitalizations and child deaths globally.
Viral Gastroenteritis Market Segment Insights
The global viral gastroenteritis market is segmented on the basis of type of virus, diagnosis, drugs, indication, and end user.
On the basis of type of virus, market is segmented into norovirus, rotavirus, astrovirus, and enteric adenovirus.
On the basis of diagnosis, the market is segmented into physical examination and rapid stool test.
On the basis of drugs, the market is segmented into Antibiotics, antacids, laxatives, antimotility agents and others. Other drugs are antiemetics and chemotherapy drugs.
On the basis of indication, the market is segmented into watery diarrhea, vomiting, abdominal cramps and pain and others.
On the basis of end user, the market is segmented into hospitals, clinics, pharmaceutical companies, diagnostic centers, ambulatory care centers and others.
Viral Gastroenteritis Regional Insights
America is the largest market for viral gastroenteritis owing to rising prevalence of viral gastroenteritis in the U.S., especially among the pediatric population. According to the Center For Disease Control And Prevention (CDC), each year on average in the United States, there are 19 to 21 million cases of acute gastroenteritis.
Europe is the second largest market for viral gastroenteritis. According to an article published in the journal of Clinical Virology, in Europe, acute infectious gastroenteritis is one of the major causes for substantial morbidity and economic loss.
In Asia Pacific, the common cause of severe gastroenteritis in children less than 5 years of age, is rotavirus. The market in Asia Pacific is driven by an increasing demand for rapid diagnostic tests for gastrointestinal diseases and increasing awareness about available treatment options for viral gastroenteritis. Also, growing investments in the field of life science research and demand for advanced therapies for the treatment of gastrointestinal diseases in developing nations such as China and India will propel the growth of the Asia Pacific market.
The Middle East & Africa also show a steady rise in the market owing to increasing number of cases of diarrhea due to viral infection.
Key Players in the Global Viral Gastroenteritis Market
- Valeant Pharmaceuticals International Inc. (U.S.)
- Janssen Global Services, LLC (U.S.)
- Takeda Pharmaceutical (Japan)
- Bayer AG (Germany)
- Sanofi (France)
- Allergan (Ireland)
- GlaxoSmithKline (U.S.)
- Abbott (U.S.)
- AstraZeneca (U.K)
Research Methodology
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Intended Audience
- Gastrointestinal Drug Manufacturers
- Gastrointestinal Drug Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
